Skip to Content
Merck
  • Cytokeratin 5/6 in normal human breast: lack of evidence for a stem cell phenotype.

Cytokeratin 5/6 in normal human breast: lack of evidence for a stem cell phenotype.

The Journal of pathology (2004-09-18)
Catherine L Clarke, Jennifer Sandle, Suzanne C Parry, Jorge S Reis-Filho, Michael J O'Hare, Sunil R Lakhani
ABSTRACT

In recent studies, Böcker and colleagues described a population of cells in paraffin wax sections of normal human breast that express cytokeratins (CK) 5/6 without expression of CK8/18 or smooth muscle actin (SMA). They proposed that these represent stem cells that give rise to differentiated luminal and myoepithelial cells. The data have been used to generate a model for breast cancer progression and classification with associated implications for management of pre-invasive disease. In this study, the expression of CK5/6, CK8/18, and SMA was investigated using multiple immunofluorescence on matched pairs of paraffin wax-embedded and frozen breast specimens. The staining patterns reported previously in antigen-retrieved paraffin wax-embedded sections were confirmed but no CK5/6-only cells were found in frozen sections of normal breast. There were cells with low levels of CK8/18 expression in frozen sections that may correspond to the CK8/18 'negative' cells seen in paraffin wax sections. This study brings into question the previously described profile of breast 'stem cells' based on CK5/6 staining and hence the breast cancer progression model and classification based on this phenotype.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Cytokeratin 5 (EP1601Y) Rabbit Monoclonal Primary Antibody